Wird geladen...
Plasma Exchange for Immune Checkpoint Inhibitor–Induced Myocarditis
Immune checkpoint inhibitor therapy has been shown to improve outcomes across many types of malignancies. However, immune checkpoint inhibitor has been associated with several immune-related adverse events including myocarditis. We describe the case of a 69-year-old man with fulminant myocarditis li...
Gespeichert in:
| Veröffentlicht in: | CJC Open |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7984993/ https://ncbi.nlm.nih.gov/pubmed/33778457 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cjco.2020.11.004 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|